Groww Logo
Home>US Stocks>Supernus Pharmaceuticals Inc
S

Supernus Pharmaceuticals Inc

Healthcare
$27.48
+ $0.37 (1.36%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $27.40$27.11376,436526,996

      Fundamentals

      Market Cap$1.46B
      P/B Ratio1.8
      P/E Ratio20
      Enterprise Value$1.79B
      Div. Yield0.00%
      Book Value15.53
      EPS(TTM)0.48
      ROENA
      Understand Fundamentals

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on Supernus Pharmaceuticals Inc

      Can I Buy Supernus Pharmaceuticals Inc Shares in India?

      Yes, Supernus Pharmaceuticals Inc shares can be bought in India by opening an international trading account with Groww.

      How to Buy Supernus Pharmaceuticals Inc Shares in India?

      One can easily invest in Supernus Pharmaceuticals Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Supernus Pharmaceuticals Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Supernus Pharmaceuticals Inc.

      What is the Share Price of Supernus Pharmaceuticals Inc?

      The share price of Supernus Pharmaceuticals Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Supernus Pharmaceuticals Inc share price is $27.48 as of 20 May ‘22

      What is the Market Cap of Supernus Pharmaceuticals Inc?

      The Supernus Pharmaceuticals Inc market cap is $1.46B as of 20 May ‘22

      What is the PE and PB ratio of Supernus Pharmaceuticals Inc?

      The PE and PB ratio of Supernus Pharmaceuticals Inc is 20 and 1.8 as of 20 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.3.8
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW